Potent antinociceptive effects of kelatorphan (a highly efficient inhibitor of multiple enkephalin-degrading enzymes) systemically administered in normal and arthritic rats
- PMID: 2790459
- DOI: 10.1016/0006-8993(89)90974-8
Potent antinociceptive effects of kelatorphan (a highly efficient inhibitor of multiple enkephalin-degrading enzymes) systemically administered in normal and arthritic rats
Abstract
The effects of various i.v. doses (2.5, 5, 10 and 15 mg/kg) of the highly efficient inhibitor of multiple enkephalin-degrading enzymes, Kelatorphan, were evaluated on the vocalization threshold to paw pressure in normal rats and in rats with Freund's adjuvant-induced arthritis. In normal rats, Kelatorphan at doses as low as 2.5 mg/kg i.v. at which the enkephalinase inhibitor acetorphan was ineffective, produced potent antinociceptive effects, comparable to that induced by 1 mg/kg i.v. morphine. In contrast, for the higher doses used (5, 10, 15 mg/kg i.v.), the effects of Kelatorphan were not more pronounced than that of acetorphan. Unlike acetorphan, Kelatorphan was found to be much more effective in arthritic than in normal rats in raising the vocalization threshold, even at the lower concentration, 2.5 mg/kg i.v.: 244% in arthritic vs 144% in normal rats. The effects of Kelatorphan were prevented by naloxone at the dose of 0.5 mg/kg i.v. The enhanced potency of Kelatorphan is discussed in relation with the increase in peptidase-sensitive dynorphin fragments in arthritic rats.
Similar articles
-
Antinociceptive effect of systemic PC 12, a prodrug mixed inhibitor of enkephalin-degrading enzymes, in normal and arthritic rats.Eur J Pharmacol. 1993 Sep 7;241(1):129-33. doi: 10.1016/0014-2999(93)90944-d. Eur J Pharmacol. 1993. PMID: 7901035
-
The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats.Brain Res. 1983 May 9;267(1):131-8. doi: 10.1016/0006-8993(83)91046-6. Brain Res. 1983. PMID: 6574799
-
In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.Eur J Pharmacol. 1985 Nov 5;117(2):233-43. doi: 10.1016/0014-2999(85)90608-9. Eur J Pharmacol. 1985. PMID: 3865779
-
Spinorphin as an endogenous inhibitor of enkephalin-degrading enzymes: roles in pain and inflammation.Curr Protein Pept Sci. 2002 Dec;3(6):587-99. doi: 10.2174/1389203023380404. Curr Protein Pept Sci. 2002. PMID: 12470213 Review.
-
Dual Enkephalinase Inhibitors and Their Role in Chronic Pain Management.Curr Pain Headache Rep. 2021 Mar 24;25(5):29. doi: 10.1007/s11916-021-00949-0. Curr Pain Headache Rep. 2021. PMID: 33761014 Review.
Cited by
-
Spinal opioid systems in inflammation.Inflamm Res. 1995 Jun;44(6):231-41. doi: 10.1007/BF01782974. Inflamm Res. 1995. PMID: 7583517 Review.
-
Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.Nat Rev Drug Discov. 2012 Apr;11(4):292-310. doi: 10.1038/nrd3673. Nat Rev Drug Discov. 2012. PMID: 22460123 Review.
-
The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder.Neuropharmacology. 2023 Mar 1;225:109376. doi: 10.1016/j.neuropharm.2022.109376. Epub 2022 Dec 11. Neuropharmacology. 2023. PMID: 36516892 Free PMC article. Review.
-
Aminophosphinic inhibitors as transition state analogues of enkephalin-degrading enzymes: a class of central analgesics.Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12028-33. doi: 10.1073/pnas.95.20.12028. Proc Natl Acad Sci U S A. 1998. PMID: 9751784 Free PMC article.
-
A comprehensive review of the pharmacodynamics, pharmacokinetics, and clinical effects of the neutral endopeptidase inhibitor racecadotril.Front Pharmacol. 2012 May 30;3:93. doi: 10.3389/fphar.2012.00093. eCollection 2012. Front Pharmacol. 2012. PMID: 22661949 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
